PE20050677A1 - Esteroides con perfil androgenico y progestagenico mixto - Google Patents

Esteroides con perfil androgenico y progestagenico mixto

Info

Publication number
PE20050677A1
PE20050677A1 PE2004001245A PE2004001245A PE20050677A1 PE 20050677 A1 PE20050677 A1 PE 20050677A1 PE 2004001245 A PE2004001245 A PE 2004001245A PE 2004001245 A PE2004001245 A PE 2004001245A PE 20050677 A1 PE20050677 A1 PE 20050677A1
Authority
PE
Peru
Prior art keywords
homoestr
hydroxy
progestagenic
steroids
mixed
Prior art date
Application number
PE2004001245A
Other languages
English (en)
Inventor
Arij Jan Grootenhuis
Der Louw Jaap Van
Gooijer Marcel Evert De
Dirk Leysen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20050677A1 publication Critical patent/PE20050677A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

REFERIDA A 19-NOR-D-HOMOESTEROIDES DE FORMULA I DONDE R1 ES O, NOH, NO-ALQUIL(C1-C6), ENTRE OTROS; R2 ES METIL, ETIL; R3 ES H, ACIL(C1-C15). SON COMPUESTOS PREFERIDOS: (7a,17ab)-17a-HIDROXI-7,17a-DIMETIL-D-HOMOESTR-4-EN-3-UNO-(7a-17ab)-17a-HIDROXI-7,17a-DIMETIL-D-HOMOESTR-4-EN-3-UNO; (7a,17ab)-17a-ETIL-17a-HIDROXI-7-METIL-D-HOMOESTR-4-EN-3-UNO-(7a-17ab)-17a-ETIL-17a-HIDROXI-7-METIL-D-HOMOESTR-4-EN-3-UNO; ENTRE OTROS. DICHOS COMPUESTOS PREVIENEN LA PERDIDA DE DENSIDAD MINERAL OSEA TRABECULAR (BMD)
PE2004001245A 2003-12-22 2004-12-10 Esteroides con perfil androgenico y progestagenico mixto PE20050677A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03104898 2003-12-22

Publications (1)

Publication Number Publication Date
PE20050677A1 true PE20050677A1 (es) 2005-10-04

Family

ID=34707282

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004001245A PE20050677A1 (es) 2003-12-22 2004-12-10 Esteroides con perfil androgenico y progestagenico mixto

Country Status (30)

Country Link
US (1) US7582622B2 (es)
EP (1) EP1720895B1 (es)
JP (1) JP2007515455A (es)
KR (1) KR20060123484A (es)
CN (1) CN1898258B (es)
AR (1) AR046966A1 (es)
AT (1) ATE373674T1 (es)
AU (1) AU2004303524A1 (es)
BR (1) BRPI0417781A (es)
CA (1) CA2549148A1 (es)
CY (1) CY1106935T1 (es)
DE (1) DE602004009107T2 (es)
DK (1) DK1720895T3 (es)
EC (1) ECSP066666A (es)
ES (1) ES2294569T3 (es)
HR (1) HRP20070492T3 (es)
IL (1) IL175890A0 (es)
IS (1) IS8488A (es)
MX (1) MXPA06007195A (es)
NO (1) NO20062585L (es)
NZ (1) NZ547772A (es)
PE (1) PE20050677A1 (es)
PL (1) PL1720895T3 (es)
PT (1) PT1720895E (es)
RU (1) RU2357972C2 (es)
SI (1) SI1720895T1 (es)
TW (1) TW200521134A (es)
UA (1) UA84037C2 (es)
WO (1) WO2005061528A2 (es)
ZA (1) ZA200604976B (es)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959322A (en) * 1960-09-22 1976-05-25 Herchel Smith Synthesis of 13-alkyl-gon-4-ones
NL125069C (es) * 1963-12-24
FR1434172A (fr) 1963-12-24 1966-04-08 Ciba Geigy Procédé de préparation de nouvelles oestrones substituées
US4412993A (en) * 1980-01-25 1983-11-01 The Upjohn Company Method of treating pseudopregnancy, galactorrhea and mastitis in mammals
US4788218A (en) * 1984-05-21 1988-11-29 Sri International 17 a β-hydroxy-7 α-methyl-d-homo-19-norandrost-4,16-diene-3-one and the 17-esters thereof: methods of preparation and uses
JPS61502186A (ja) * 1984-05-21 1986-10-02 エス・ア−ル・アイ・インタ−ナシヨナル １７αβ−ヒドロキシ−７α−メチル−Ｄ−ホモ−１９−ノルアンドロスト−４，１６−ジエン−３−オンおよびその１７−エステル、ならびにその製法および使用
CZ293319B6 (cs) 1998-06-19 2004-04-14 Akzo Nobel N. V. Derivát testosteronu a farmaceutický prostředek s jeho obsahem
ATE228143T1 (de) 1999-03-08 2002-12-15 Akzo Nobel Nv 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene
ATE246703T1 (de) 1999-04-06 2003-08-15 Akzo Nobel Nv Oral wirksame 7-alpha-alkyl androgene
TW548277B (en) 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens

Also Published As

Publication number Publication date
MXPA06007195A (es) 2006-09-04
US20070155836A1 (en) 2007-07-05
AU2004303524A1 (en) 2005-07-07
KR20060123484A (ko) 2006-12-01
UA84037C2 (ru) 2008-09-10
DE602004009107D1 (de) 2007-10-31
IS8488A (is) 2006-05-26
BRPI0417781A (pt) 2007-03-20
CA2549148A1 (en) 2005-07-07
ES2294569T3 (es) 2008-04-01
US7582622B2 (en) 2009-09-01
WO2005061528A3 (en) 2005-09-09
NO20062585L (no) 2006-09-20
DK1720895T3 (da) 2008-01-14
RU2357972C2 (ru) 2009-06-10
CN1898258B (zh) 2010-06-16
RU2006126632A (ru) 2008-01-27
CN1898258A (zh) 2007-01-17
HRP20070492T3 (en) 2007-12-31
NZ547772A (en) 2009-01-31
PL1720895T3 (pl) 2008-02-29
EP1720895A2 (en) 2006-11-15
WO2005061528A2 (en) 2005-07-07
ZA200604976B (en) 2007-04-25
PT1720895E (pt) 2007-10-09
TW200521134A (en) 2005-07-01
EP1720895B1 (en) 2007-09-19
JP2007515455A (ja) 2007-06-14
CY1106935T1 (el) 2012-09-26
ATE373674T1 (de) 2007-10-15
SI1720895T1 (sl) 2007-12-31
ECSP066666A (es) 2006-10-25
IL175890A0 (en) 2006-10-05
DE602004009107T2 (de) 2008-06-19
AR046966A1 (es) 2006-01-04

Similar Documents

Publication Publication Date Title
MY135094A (en) Ready-mixed setting-type composition and related kit
SG158886A1 (en) Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
DK1501507T3 (da) Tetrahydropyranyl-cyclopentyl-tertrahydropyridopyrindin-modulatorer af kemokin-receptor-aktivitet
DE60126785D1 (de) Nicht-imidazol aryloxypiperidine als h3 rezeptor liganden
DE60330150D1 (en) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
MXPA04001953A (es) Particulas micro-granulosas.
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
GB2405636B (en) Dual function cement additive
RS51389B (en) BENZIMIDAZOLE COMPOUNDS
BRPI0414992A (pt) composição retardadora de chama
ZA200500436B (en) 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
PE20010678A1 (es) Tratamiento de enfisema usando antagonistas retinoides selectivos de rar
CR9318A (es) Compuestos de cinolina y su uso como moduladores de receptor x de higado
HK1045990A1 (en) Novel derivatives and analogues of galanthamin.
PE20050677A1 (es) Esteroides con perfil androgenico y progestagenico mixto
EP1655291A4 (en) COMPOUNDS WITH THROMBOPOIETIN RECEPTOR AGONISM
NO20022977D0 (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
PE20090931A1 (es) Composicion farmaceutica que contiene un inhibidor de esteroide c17,20 liasa
DE502005002163D1 (de) Verfahren zur herstellung von hochfestem, säurebeständigem beton
CO5050291A1 (es) Mezclas fungicidas que comprenden un oxim eter carboxilato o una eter carboxamida y al menos un compuesto fungicida adicional
MXPA05012279A (es) Derivados de bencil sulfonamida.
PE20070020A1 (es) Esteroides que tienen un perfil mixto de efectos androgenicos y progestagenicos
BR0317151A (pt) Misturas de agentes de branqueamento fluorescentes
NZ520805A (en) Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
PE20020752A1 (es) Esteroides con doble enlace delta 14 sustituido en las posiciones 13 y 14 con actividad androgenica y progestagena

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed